The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.

Fresh off a 12% surge on the news that Warren Buffett's Berkshire Hathaway, as well as other leading investors, purchased the ...

U.S. stock futures showed little movement ahead of a critical Washington meeting between President Donald Trump and Ukrainian ...